+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mitsubishi Tanabe Pharma Corporation - logo

Mitsubishi Tanabe Pharma manufactures pharmaceuticals, primarily ethical drugs in Japan. It focuses on the fields of circulatory system and metabolism, neuropsychiatry, the respiratory system and immunology, and oncology and hepatology. It sells products such as anticoagulant Anplag, anti-allergy medicine Talion, liver drug Urso, and neuroprotective agent Radicut. The company was founded in 1901 and is headquartered in Osaka, Japan.

Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • December 2023
  • 181 Pages
  • Global
From
Endometriosis - Pipeline Insight, 2021 - Product Thumbnail Image

Endometriosis - Pipeline Insight, 2021

  • Clinical Trials
  • July 2021
  • 60 Pages
  • Global
From
Global Axial Spondyloarthritis (axSpA) Market Report 2023 - Product Thumbnail Image

Global Axial Spondyloarthritis (axSpA) Market Report 2023

  • Report
  • October 2023
  • 175 Pages
  • Global
From
Global Janus Kinase (JAK) Inhibitors Market Report 2023 - Product Thumbnail Image

Global Janus Kinase (JAK) Inhibitors Market Report 2023

  • Report
  • October 2023
  • 175 Pages
  • Global
From
Amyotrophic Lateral Sclerosis: Global Strategic Business Report - Product Thumbnail Image

Amyotrophic Lateral Sclerosis: Global Strategic Business Report

  • Report
  • December 2023
  • 183 Pages
  • Global
From
Myasthenia Gravis Drugs - Global Strategic Business Report - Product Thumbnail Image

Myasthenia Gravis Drugs - Global Strategic Business Report

  • Report
  • December 2023
  • 182 Pages
  • Global
From
From
From
From
Leukotriene D4 Antagonist - Pipeline Insight, 2022 - Product Thumbnail Image

Leukotriene D4 Antagonist - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
  • Global
From
Asthma Therapeutics: Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics: Global Strategic Business Report

  • Report
  • December 2023
  • 194 Pages
  • Global
From
From
Rare Neurological Disease Treatment Global Market Report 2023 - Product Thumbnail Image

Rare Neurological Disease Treatment Global Market Report 2023

  • Report
  • September 2023
  • 175 Pages
  • Global
From
Drugs for Rheumatoid Arthritis: Global Markets to 2022 - Product Thumbnail Image

Drugs for Rheumatoid Arthritis: Global Markets to 2022

  • Report
  • March 2018
  • 182 Pages
  • Global
From
Loading Indicator